Evidence map›Paper›PMID 34276076›Full record

ArticleQuality & quantity2022

Implementation of the SutteARIMA method to predict short-term cases of stock market and COVID-19 pandemic in USA.

Pawan Kumar Singh, Anushka Chouhan, Rajiv Kumar Bhatt, Ravi Kiran, Ansari Saleh Ahmar

Abstract read
In one paragraph

Article in Quality & quantity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Application of an ARFIMA Model to Estimate Hepatitis C Epidemics in Henan, China.The American journal of tropical medicine and hygiene · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pawan Kumar SinghSchool of Humanities and Social Sciences, Thapar Institute of Engineering and Technology, Patiala, Punjab 147004 India.ORCID 0000-0002-4822-886X
Anushka ChouhanDepartment of Economics, Banaras Hindu University, Varanasi, Uttar Pradesh 221005 India.
Rajiv Kumar BhattDepartment of Economics, Banaras Hindu University, Varanasi, Uttar Pradesh 221005 India.
Ravi KiranSchool of Humanities and Social Sciences, Thapar Institute of Engineering and Technology, Patiala, Punjab 147004 India.
Ansari Saleh AhmarDepartment of Statistics, Faculty of Mathematics and Natural Sciences, Universitas Negeri Makassar, Makassar, 90224 Indonesia.ORCID https://orcid.org/0000-0001-6888-9043

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to compare the different methods which are effective in predicting data of the short-term effect of COVID-19 confirmed cases and DJI closed stock market in the US. Data for confirmed cases of COVID-19 has been obtained from Worldometer, the database of Johns Hopkins University and the US stock market data (DJI) was obtained from Yahoo Finance. The data starts from 20 January 2020 (first confirmed COVID-19 case the US) to 06 December 2020 and DJI data covers 21 January 2019 to 04 December 2020. COVID-19 data was tested for the period 30 November to 06 December and DJI from 25 November 2020 to 04 December. From the result, we find that the method SutteARIMA was found more suitable to calculate the daily forecasts of COVID-29 confirmed cases and DJI in the US and this method has been used in this study. For the evaluation of the prediction methods, the accuracy measure means absolute percentage error (MAPE) has been used. The MAPE value with the SutteARIMA of 0.56 and 0.60 for COVID-19 and DJI stock respectively was found to be smaller than the MAPE value with ARIMA method.

Indexed as

COVID-19DJIShort-term forecastSutteARIMA

Identifiers

PMID34276076
PMCPMC8277990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.